Federal Court Upholds West Virginia Law that Reins in “Bad Drug” Ads
In a victory for patient protections, a federal appellate court upheld a West Virginia law designed to put guardrails on unscrupulous “bad drug” advertising.
One-sided Ads Put Patients’ Health at Risk
It’s Time to Rein In Dangerous “Bad Drug” Ads
By Frank Lavernia, MD
As one of the many physicians who has seen patients harmed by misleading television advertisements, I urge policymakers to make this the year they rein in “bad drug” ads.
Lawmakers & Regulators Tackle “Bad Drug” Ads
“Bad drug” ads often target seniors with misinformation about prescription medications, with their scare tactics costing viewers their health – even their lives. Now the Federal Trade Commission is highlighting the importance of protecting consumers from questionable advertising practices.
"Bad Drug" Ads Make for Bad Decisions
West Virginia Curbs Misleading "Bad Drug" Ads
Federal Trade Commission Stands with Patients on "Bad Drug" Ads
For years, patients have been misled by “bad drug” ads that frighten them into abandoning their prescription medications. Now the Federal Trade Commission is speaking out.